Literature DB >> 23743178

What is low threshold methadone maintenance treatment?

Carol Strike1, Margaret Millson2, Shaun Hopkins3, Christopher Smith4.   

Abstract

BACKGROUND: Low threshold methadone maintenance (MMT) was developed for clients who do not have abstinence as a treatment goal. We explored how MMT programs in Canada defined low threshold and the challenges they faced.
METHODS: Using semi-structured interviews, we collected data from clients (n=46), nurses/counsellors (n=15) and physicians (n=9) at three low threshold MMT programs. All participants were asked to define low threshold MMT and describe how it was implemented in practice. Interviews were taped, transcribed, verified and analysed using an iterative thematic coding technique.
RESULTS: Low threshold MMT was defined by an explicit rejection of abstinence from opiates and other drugs as an over-arching treatment goal. In the absence of guidelines defining a set of practices as low threshold, programs implemented practices they believed would reduce barriers to admission and help retention. There was not always agreement between professional groups or across the programs regarding these practices. For physicians, there was a tension between accepting poly-drug use during treatment as a means to improve retention, with an obligation to do more good than harm for their patients. Missed prescribing appointments generated few to severe consequences and revealed differential focus on reducing barriers versus encouraging client 'ownership' of treatment. Differences of opinion regarding appropriate urine drug testing practices revealed power dynamics between medical and non-medical staff.
CONCLUSION: Our findings show that there are potentially more ways to reduce barriers to MMT than those presented in the current literature. Our findings are important given the growing number of people with opiate dependence across the world and calls to increase access to MMT. To fully develop the low threshold model, it will be important to evaluate what policies and practices can achieve the goals of reducing barriers to admission and improving retention in treatment.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Canada; Harm reduction; Low threshold; Methadone maintenance; Program policies

Mesh:

Substances:

Year:  2013        PMID: 23743178     DOI: 10.1016/j.drugpo.2013.05.005

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  16 in total

1.  Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.

Authors:  Ryan McNeil; Thomas Kerr; Solanna Anderson; Lisa Maher; Chereece Keewatin; M J Milloy; Evan Wood; Will Small
Journal:  Soc Sci Med       Date:  2015-04-07       Impact factor: 4.634

Review 2.  Integrated opioid substitution therapy and HIV care: a qualitative systematic review and synthesis of client and provider experiences.

Authors:  Andy Guise; Maureen Seguin; Gitau Mburu; Susie McLean; Pippa Grenfell; Zahed Islam; Sergii Filippovych; Happy Assan; Andrea Low; Peter Vickerman; Tim Rhodes
Journal:  AIDS Care       Date:  2017-03-10

3.  Initiating HCV treatment with direct acting agents in opioid agonist treatment: When to start for people co-infected with HIV?

Authors:  Dimitra Panagiotoglou; Emanuel Krebs; Jeong Eun Min; Michelle Olding; Keith Ahamad; Lianping Ti; Julio S G Montaner; Bohdan Nosyk
Journal:  Int J Drug Policy       Date:  2017-06-01

4.  Assessing the Temporality Between Transitions onto Opioid Agonist Therapy and Engagement with Antiretroviral Therapy in a Cohort of HIV-Positive People Who Use Opioids Daily.

Authors:  Sanjana Mitra; Cameron Grant; Seonaid Nolan; Nur Afiqah Mohd Salleh; M-J Milloy; Lindsey Richardson
Journal:  AIDS Behav       Date:  2022-01-03

Review 5.  The role of prevention strategies in achieving HCV elimination in Canada: what are the remaining challenges?

Authors:  Stine Bordier Høj; Nanor Minoyan; Andreea Adelina Artenie; Jason Grebely; Julie Bruneau
Journal:  Can Liver J       Date:  2018-07-17

6.  'Crisis' and 'everyday' initiators: A qualitative study of coercion and agency in the context of methadone maintenance treatment initiation.

Authors:  Will Damon; Will Small; Solanna Anderson; Lisa Maher; Evan Wood; Thomas Kerr; Ryan McNeil
Journal:  Drug Alcohol Rev       Date:  2016-04-29

7.  Predictors of injecting cessation among a cohort of people who inject drugs in Tijuana, Mexico.

Authors:  Danielle Horyniak; Steffanie A Strathdee; Brooke S West; Meredith Meacham; Gudelia Rangel; Tommi L Gaines
Journal:  Drug Alcohol Depend       Date:  2018-02-21       Impact factor: 4.492

8.  Understanding concurrent stimulant use among people on methadone: A qualitative study.

Authors:  Ryan McNeil; Nitsaha Puri; Jade Boyd; Samara Mayer; Kanna Hayashi; Will Small
Journal:  Drug Alcohol Rev       Date:  2020-03

9.  "That's No Longer Tolerated": Policing Patients' Use of Non-opioid Substances in Methadone Maintenance Treatment.

Authors:  David Frank
Journal:  J Psychoactive Drugs       Date:  2020-09-30

10.  Methadone maintenance treatment is swapping one drug for another, and that's why it works: Towards a treatment-based critique of the war on drugs.

Authors:  David Frank
Journal:  Int J Drug Policy       Date:  2020-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.